Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 31;52(1):27-34.
doi: 10.28920/dhm52.1.27-34.

Hyperbaric oxygen treatment for refractory haemorrhagic cystitis occurring after chemotherapy and haematopoietic stem cell transplantation: retrospective analysis of 25 patients

Handan Ozturk  1 , Bengusu Mirasoglu  2   3 , Samil Aktas  2
Affiliations

Hyperbaric oxygen treatment for refractory haemorrhagic cystitis occurring after chemotherapy and haematopoietic stem cell transplantation: retrospective analysis of 25 patients

Handan Ozturk et al. Diving Hyperb Med. .

Abstract

Introduction: Intractable haemorrhagic cystitis (HC) is a serious complication of chemotherapy (CT) and haematopoietic stem cell transplantation (HSCT). Hyperbaric oxygen treatment (HBOT) is a promising treatment option based on the similarities in injury pattern and observed histological changes with radiation induced HC, which is an approved indication. We present our experience with HBOT in HC occurring after CT and HSCT.

Methods: Medical files of patients who underwent HBOT between the years 2000-2020 for HC that developed after chemotherapy and/or HSCT were reviewed. Demographic data, primary diagnosis, history of HC and details of HBOT were documented. Treatment outcomes were grouped as complete and partial healing, no response and deterioration.

Results: Twenty-five patients underwent a median of 12 HBOT sessions for HC occurring after CT and HSCT. Complete healing was observed in 11 patients whereas haematuria improved in seven patients. HC grades after HBOT were significantly better than referral grades. A significant correlation was shown with the number of HBOT sessions and change in haematuria. Patients who underwent seven or more HBOT sessions benefitted most.

Conclusions: HBOT appears to be a safe and effective treatment for refractory HC following CT and HSCT. Higher quality evidence would be needed to prove efficacy. However, given the difficulty of conducting randomised controlled trials on such a vulnerable and small group of patients with few treatment options, and given the consistency of current observational evidence, HC occurring after CT and HSCT may be considered as an optional or investigational indication for HBOT.

Keywords: Cyclophosphamide; Hematopoietic stem cell transplantation; Hemorrhagic cystitis; Hyperbaric research.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest and funding: nil

Figures

Figure 1
Figure 1
Change in the number of patients in each haemorrhagic cystitis grade group before and after HBOT
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol. 2010;26:156–66. doi: 10.4103/0970-1591.65380. - DOI - PMC - PubMed
    1. Haldar S, Dru C, Bhowmick NA. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2014;2:199–208. - PMC - PubMed
    1. Hannick JH, Koyle MA. Canadian Urological Association best practice report: pediatric hemorrhagic cystitis. Can Urol Assoc J. 2019;13:E325–E334. doi: 10.5489/cuaj.5993. - DOI - PMC - PubMed
    1. Payne H, Adamson A, Bahl A, Borwell J, Dodds J, Heath C, et al. Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int. 2013;112:885–97. doi: 10.1111/bju.12291. - DOI - PMC - PubMed
    1. Matz EL, Hsieh MH. Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis . Urology. 2017;100:16–9. doi: 10.1016/j.urology.2016.07.030. - DOI - PubMed

MeSH terms

LinkOut - more resources